GOOG vs LLY: Which Is the Better Buy?
Side-by-side comparison of Alphabet Inc. and Eli Lilly and Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Alphabet Inc. · Communication Services
$355.03
-17.2% upside to fair value
Grade D
High Quality
VS
Eli Lilly and Company · Healthcare
$1,179.09
+31.7% upside to fair value
High Conviction
Grade A
High Quality
QuantHub Verdict
LLY has more upside to fair value
(+31.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GOOG |
LLY |
| Current Price |
$355.03 |
$1,179.09 |
| Fair Value Estimate |
$294.10 |
$1,552.32 |
| Upside to Fair Value |
-17.2%
|
+31.7%
|
| Market Cap |
$4,320.1B |
$1,110.4B |
| Forward P/E |
27.0x
|
—
|
| EV / EBITDA |
20.0x
|
34.3x
|
| Price / Sales |
10.2x
|
14.6x
|
| Price / FCF |
67.0x
|
77.7x
|
| Revenue Growth YoY |
+21.8%
|
+55.5%
|
| Gross Margin |
60.4%
|
83.5%
|
| Operating Margin |
32.7%
|
45.9%
|
| Return on Equity |
39.0%
|
101.3%
|
| Dividend Yield |
0% |
0.55% |
| FCF Yield |
1.49%
|
1.29%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Alphabet Inc. operates as a global leader in internet content and information services, primarily through its dominant search engine, advertising platforms, and cloud services. The company exhibits high business quality with a durable competitive moat supported by strong network effects, brand recognition, and intangible assets. Alphabet's financials reflect robust profitability with a net margin…
Eli Lilly is a global biopharma company whose exceptionally profitable cardiometabolic franchises, led by Mounjaro and Zepbound, are driving a high-quality growth phase: revenue rose 55.5% year over year and earnings rose 168.0% year over year in the most recent quarter, while gross, operating, and net margins were 83.5%, 45.9%, and 35.0%, respectively. Business quality is high because tirzepatid…
Accumulation Zones
| Metric |
GOOG |
LLY |
| Zone Low |
$220.58 |
$1,164.24 |
| Zone High |
$249.99 |
$1,319.47 |
| In Buy Zone? |
No
|
Yes
|